Live Webinar on "How to Invest successfully to reach goals without losing sleep" Sign up for Live Webinar

Glenmark Pharma transfers API business to Glenmark Life Sciences

02 Jan 2019

Glenmark Pharmaceuticals has transferred its Active Pharmaceuticals Ingredient (API) business to Glenmark Life Sciences, a wholly owned subsidiary of the company. This transfer was completed on December 31, 2018.

Glenmark Pharmaceuticals is a global pharmaceutical company. The company is engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs). Its segments are India, United States, Latin America, Europe and Rest of the World (ROW).

Related Glenmark Pharmaceuticals Ltd. Links:

Glenmark Pharma Share Price

524.75 -5.00 (-0.94%) Oct 14, 18:01
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 841.05
Cipla 911.50
Dr. Reddy's Lab 4959.70
Aurobindo Pharma 726.65
Lupin 946.10
View more..
Sensex vs Glenmark Pharma
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback